GO Term | Evidence Code | PMID |
---|---|---|
response to follicle-stimulating hormone | ||
negative regulation of cell migration | ||
positive regulation of smooth muscle cell migration | ||
response to 3-methylcholanthrene | ||
cellular response to progesterone stimulus |
GO Term | Evidence Code | PMID |
---|---|---|
intracellular membrane-bounded organelle | ||
endoplasmic reticulum membrane |
|
|
mitochondrion |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:13094 | branch retinal artery occlusion | |
DOID:13098 | central retinal artery occlusion | |
DOID:13174 | dissociated nystagmus | |
DOID:1319 | brain cancer | |
DOID:13206 | nodular prostate | |
DOID:13223 | uterine fibroid | |
DOID:1324 | lung cancer | |
DOID:1325 | bronchus cancer | |
DOID:13515 | tuberous sclerosis | |
DOID:13544 | low tension glaucoma |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000486 | Strabismus |
HP:0000501 | Glaucoma |
HP:0000505 | Visual impairment |
HP:0000523 | Subcapsular cataract |
HP:0000525 | Abnormality iris morphology |
HP:0000541 | Retinal detachment |
HP:0000557 | Buphthalmos |
HP:0000572 | Visual loss |
HP:0000587 | Abnormal optic nerve morphology |
Disease ID | Disease Name |
---|---|
OMIM:617315 |
|
ORPHA:98976 |
|
OMIM:600975 |
|
ORPHA:98977 |
|
ORPHA:708 |
|
OMIM:231300 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
511470 | BOVIN02261 | ||
102184252 | CAPHI01621 | ||
101119706 | SHEEP13930 | ||
100358590 | RABIT08711 | ||
105986861 | DIPOR07022 | ||
13078 | MGI:88590 | MOUSE22049 | |
25426 | RGD:2460 | RATNO34963 | |
100719054 | CAVPO09787 | ||
101580968 | OCTDE05259 | ||
100011610 | MONDO08028 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024